Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 28, 2018	Feb. 28, 2017
Cash flows from operating activities:
Net income (loss)	$ (71,255)	$ 14,259
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Equity in (income) loss of unconsolidated joint ventures	426	(760)
Proceeds from Equity Method Investment, Distribution	1,300	0
Amortization of discounts and issuance costs	1,552	1,665
Depreciation and amortization	628	802
Deferred income taxes	117,068	7,100
Loss on early extinguishment of debt	0	5,685
Stock-based compensation	3,829	3,152
Inventory impairments and land option contract abandonments	4,985	4,008
Changes in assets and liabilities:
Receivables	(6,024)	(6,788)
Inventories	(135,311)	(36,878)
Accounts payable, accrued expenses and other liabilities	(54,016)	(64,105)
Other, net	(4,862)	(5,182)
Net cash used in operating activities	(141,680)	(77,042)
Cash flows from investing activities:
Contributions to unconsolidated joint ventures	(8,025)	(8,750)
Proceeds from Equity Method Investment, Distribution, Return of Capital	1,099	1,107
Purchases of property and equipment, net	(1,924)	(1,015)
Net cash used in investing activities	(8,850)	(8,658)
Cash flows from financing activities:
Repayment of senior notes	0	(105,326)
Payments on mortgages and land contracts due to land sellers and other loans	(3,362)	(45,428)
Issuance of common stock under employee stock plans	2,946	662
Payments of cash dividends	(2,322)	(2,215)
Tax payments associated with stock-based compensation awards	(6,787)	(2,543)
Net cash used in financing activities	(9,525)	(154,850)
Net decrease in cash and cash equivalents	(160,055)	(240,550)
Cash and cash equivalents at beginning of period	720,861	593,000
Cash and cash equivalents at end of period	$ 560,806	$ 352,450